Seiko Narushima
- Gastroenterology top 5%
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research 8
- Immunology top 10%
- IL-33, ST2, and ILC Pathways 5
- Immune Response and Inflammation 3
- Molecular Biology top 10%
- Gut microbiota and health 12
-
- Drug Transport and Resistance Mechanisms 6
-
- Cancer Research and Treatments 4
-
- Asthma and respiratory diseases 4
-
- Helicobacter pylori-related gastroenterology studies 3
- Co-authors
- Kikuji ItohKenya HondaYukiko MiyamotoKiyohisa UchidaKenshiro OshimaYuki SugiuraMasahira HattoriMakoto Suematsu
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Seiko Narushima
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Gastroenterology 88
- Infectious Diseases 257
- Biological Psychiatry 28
- Immunology 227
- Molecular Biology 695
Countries citing papers authored by Seiko Narushima
This map shows the geographic impact of Seiko Narushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiko Narushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiko Narushima more than expected).
Fields of papers citing papers by Seiko Narushima
This network shows the impact of papers produced by Seiko Narushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiko Narushima. The network helps show where Seiko Narushima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Seiko Narushima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 21 | |
| 4 | 2019 | 132 | |
| 5 | 2018 | 21 | |
| 6 | 2017 | 109 | |
| 7 | Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation | 2017 | 9 |
| 8 | 2015 | 80 | |
| 9 | 2014 | 152 | |
| 10 | 2014 | 19 | |
| 11 | 2010 | 15 | |
| 12 | 2007 | 5 | |
| 13 | 2007 | 105 | |
| 14 | 2007 | 26 | |
| 15 | 1999 | 40 | |
| 16 | 1999 | 6 | |
| 17 | 1999 | 24 | |
| 18 | 1998 | 14 | |
| 19 | 1997 | 10 | |
| 20 | 1996 | 73 |
About Seiko Narushima
Seiko Narushima is a scholar working on Biotechnology, Clinical Biochemistry and Infectious Diseases, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gut microbiota and health (12 papers), Clostridium difficile and Clostridium perfringens research (8 papers), Drug Transport and Resistance Mechanisms (6 papers), IL-33, ST2, and ILC Pathways (5 papers), Cancer Research and Treatments (4 papers), Asthma and respiratory diseases (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Gastroenterology (88 citations), Infectious Diseases (257 citations) and Biological Psychiatry (28 citations). Seiko Narushima has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Kikuji Itoh, Kenya Honda, Yukiko Miyamoto, Kiyohisa Uchida, Kenshiro Oshima, Yuki Sugiura, Masahira Hattori, Makoto Suematsu, Koji Atarashi and Tomotari MITSUOKA. Their work appears in journals such as Science, Gastroenterology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.